Project description
Training network for the development of novel antibiotics to fight antimicrobial resistance
Multidrug resistance in bacteria requires urgent development of alternative approaches to discover novel antibiotics. Funded by the Marie Skłodowska-Curie Actions programme, the STOP SPREAD BAD BUGS project is a research training consortium that will train 15 early stage researchers in drug development, infectiology, immunology and pharmacology. Carried out by experts, the training will cover topics such as carbohydrate and protein chemistry for drug discovery, mechanisms of action of current antimicrobial compounds, and computational chemistry of the interactions of the novel antibiotics with pathogens. A range of infection models and state-of-the-art imaging tools will enable trainees to determine efficacy in preclinical tests and track the bacteria and antibiotics in these test systems.
Objective
STOP SPREAD BAD BUGS is a new multi-disciplinary research/training consortium built to combat the alarming problem of global antimicrobial resistance. Multi-drug resistance (MDR) in bacteria is becoming increasingly common thus urgently calling for alternative approaches to develop and implement novel antibiotics. We envision a definitive solution that will require a paradigm shift. Its foundation shall be the training of a new generation of future 15 Early Stage Researchers (ESRs) by world-renowned experts in the field of drug development, infectiology, immunology and pharmacology. A unique state-of the-art teaching/training pipeline shall be developed across 7 academic and 5 SME partners with complementary expertise in the development and testing of novel approaches to antimicrobial therapy in humans. We shall establish knowledge and expertise on carbohydrate and protein chemistry for the discovery of new drug candidates, while characterizing the underlying mechanism of existing compounds for treatment of microbial infections. Computational modelling shall optimize the interactions of the novel entities with selected pathogens. A range of infection models allows partners to simultaneously determine compound efficacy in pre-clinical settings and investigate the potential effects of the novel antimicrobials on host tissues. State-of-the-art imaging tools will be applied to track the bacteria and novel compounds in these test systems. Uniquely, the pipeline will also determine the pharmacokinetics, and the effects of compounds on host microbiota and host immunity. Understanding the mechanisms of action of the novel antimicrobials shall provide insights into new antimicrobial mechanisms, which may be further exploited in spin-off projects. This approach means that the STOP SPREAD BAD BUGS consortium will deliver uniquely trained, multi- and interdisciplinary ESRs that will take the continuing fight against global MDR safely into the future.
Fields of science
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- natural sciencesbiological sciencesmicrobiologybacteriology
- medical and health sciencesbasic medicinepharmacology and pharmacypharmacokinetics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistancemultidrug resistance
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Keywords
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Coordinator
3015 GD Rotterdam
Netherlands
See on map
Participants (15)
1020 Wien
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
D02 CX56 DUBLIN 2
See on map
3584 CS Utrecht
See on map
35037 Marburg
See on map
4021 Stavanger
See on map
8005 Zurich
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
9052 Zwijnaarde
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
08140 Caldes De Montbui Barcelona
See on map
16163 Genova
See on map
Participation ended
9031 Drongen
See on map
50931 Koln
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Participation ended
2560-247 TORRES VEDRAS
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
53100 Siena
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
4600 Vise
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
2630 Aartselaar
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partners (12)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
Participation ended
00074 Nemi
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
Participation ended
2820 266 Charneca De Caparica
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
Participation ended
2597 EP 's-Gravenhage (Den Haag)
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
Participation ended
67659 Kaiserslautern
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
9000 Gent
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
G12 8QQ Glasgow
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
Participation ended
1649-003 Lisboa
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
08193 Cerdanyola Del Valles
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
80539 Munchen
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
1090 Wien
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
53100 Siena
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
4000 Liege
See on map